查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941452

标靶蛋白降解 (TPD) 市场规模、份额和趋势分析报告：按类型、应用、最终用途、地区和细分市场预测，2026-2033 年

Targeted Protein Degradation Market Size, Share & Trends Analysis Report By Type, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

标靶蛋白降解 (TPD) 市场概述

2025 年全球标靶蛋白质降解 (TPD) 市场规模估计为 6.993 亿美元，预计到 2033 年将达到 32.574 亿美元。

预计从 2026 年到 2033 年，该市场将以 20.75% 的复合年增长率成长。癌症和神经退化性疾病等慢性疾病盛行率的持续上升、生活方式的改变以及医疗保健成本的上涨正在推动市场成长。

这些疾病的高发生率催生了对新型治疗方法的强劲需求，推动了市场成长。扩大该领域的研发活动蕴藏着巨大的成长机会。例如，奥地利科学基金会（FWF）于2023年12月核准了标靶蛋白降解（TPD）专项研究计画（SFB）的第二阶段资助，为期四年。标靶蛋白降解（TPD）专项研究倡议旨在理解和开发靶向特定蛋白进行细胞内降解的方法。该计划旨在推进靶向蛋白降解（TPD）领域的发展，近年来，由于其在药物发现和治疗性介入的潜在应用，该领域已引起广泛关注。

支持性的法规环境，特别是FDA和EMA等机构简化的核准流程，在加速标靶蛋白降解（TPD）治疗方法的应用方面发挥了关键作用。底层技术的快速发展正在推动TPD产业的发展。诸如蛋白水解靶向嵌合体（PROTAC）、分子黏合剂和溶酶体靶向嵌合体（LYTAC）等创新方法的开发，拓展了TPD选择性去除致病蛋白的能力。这些技术突破为标靶治疗以往无法治疗的蛋白开闢了新的途径，进而推动了TPD产业的成长。

推动该产业发展的主要动力之一是人们日益认识到标靶蛋白降解 (TPD) 作为一种治疗传统难治标靶的契机。儘管传统治疗方法往往难以应对难以调控的蛋白质，但诸如蛋白水解靶向嵌合体(PROTAC) 等技术透过促进疾病相关蛋白的降解，提供了极具前景的解决方案。这种方法在癌症和神经神经退化性疾病等疾病的治疗中展现出巨大的潜力，从而推动了该领域研发的蓬勃发展。近年来，美国国立卫生研究院 (NIH) 已将 PROTAC 列为关键药物研发技术。临床前和早期临床试验中不断取得的成功，促使製药和生物技术公司将标靶蛋白降解 (TPD) 纳入其研发管线，因为他们认识到该技术具有变革治疗策略的巨大潜力。

目录

第一章调查方法和范围

第二章执行摘要

3. 标靶蛋白质降解（TPD）市场变数与趋势

  • 市场谱系展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场动态
  • 标靶蛋白降解 (TPD) 市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章 标靶蛋白降解 (TPD) 市场：按类型分類的估算和趋势分析

  • 全球标靶蛋白质降解 (TPD) 市场按类型分類的变异分析
  • 全球标靶蛋白降解（TPD）市场规模及趋势分析（按类型划分，2021-2033年）
  • PROTAC
  • 分子黏合剂
  • LYTAC
  • 其他的

第五章 标靶蛋白降解 (TPD) 市场：按应用分類的估算与趋势分析

  • 按应用领域分析全球标靶蛋白降解 (TPD) 市场的变化
  • 全球标靶蛋白降解（TPD）市场规模及应用趋势分析（2021-2033年）
  • 药物发现
  • 药物研发
    • 癌症
    • 神经病学
    • 感染疾病
    • 循环系统疾病
    • 其他的

6. 标靶蛋白质降解 (TPD) 市场：按最终用途分類的估算和趋势分析

  • 全球标靶蛋白质降解 (TPD) 市场按最终用途分類的差异分析
  • 全球标靶蛋白降解（TPD）市场规模及趋势分析（依最终用途划分，2021-2033年）
  • 製药和生物技术公司
  • 学术和研究机构
  • 医院和临床检查室
  • 其他的

7. 标靶蛋白降解 (TPD) 市场：区域估算与趋势分析

  • 区域市场占有率分析（2025 年和 2033 年）
  • 区域市场概览
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 公司/竞争对手分类
  • 策略规划
  • 2025年商业市场分析
  • 公司简介/列表
    • Bayer AG
    • Bio-Techne
    • BOC Sciences
    • BPS Bioscience, Inc.
    • BroadPharm
    • LifeSensors Inc.
    • MedChemExpress.
    • Merck KGaA
    • Promega Corporation
    • Thermo Fisher Scientific, Inc.
Product Code: GVR-4-68040-351-3

Targeted Protein Degradation Market Summary

The global targeted protein degradation market size was estimated at USD 699.3 million in 2025 and is projected to reach USD 3,257.4 million by 2033, growing at a CAGR of 20.75% from 2026 to 2033. The constantly growing frequency of chronic disease conditions such as cancer and neurodegenerative diseases, along with changing lifestyles and increasing healthcare spending, is accelerating the market growth.

The high prevalence of these diseases creates a strong demand for novel treatment options, driving market growth. The expanding number of research and development activities in this field provides significant market growth opportunities. For instance, in December 2023, the Austrian Science Fund (FWF) approved the Special Research Program (SFB) in Targeted Protein Degradation for a second funding period of another four years. The SFB in targeted protein degradation is a research initiative focusing on understanding and developing methods to target specific proteins for cell degradation. This program aims to advance the field of targeted protein degradation, which has gained significant attention in recent years due to its potential applications in drug discovery and therapeutic interventions.

The supportive regulatory environment, particularly the streamlined approval processes by agencies such as the FDA and EMA, has played a crucial role in accelerating the adoption of TPD-based therapies. Rapid advancements in the underlying technologies drive the targeted protein degradation industry. The development of innovative approaches, such as proteolysis-targeting chimeras (PROTACs), molecular glues, and lysosome-targeting chimeras (LYTACs), has expanded TPD's capabilities to eliminate disease-causing proteins selectively. These technological breakthroughs have opened up new avenues for targeting previously undruggable proteins, driving the growth of the targeted protein degradation industry.

The increasing recognition of the therapeutic potential of targeted protein degradation in addressing previously undruggable targets is a key driver for the targeted protein degradation industry. Traditional approaches often struggle with proteins that are difficult to modulate, but technologies such as PROTACs (proteolysis-targeting chimeras) provide a favorable solution by promoting the degradation of disease-causing proteins. This method has shown considerable promise in treating conditions such as cancer and neurodegenerative disorders, sparking a surge in research and investment in this area. The National Institute of Health highlights PROTACs as a leading drug development technology in recent years. The increasing success in preclinical and early-phase clinical trials drives pharmaceutical and biotech companies to integrate targeted protein degradation into their pipelines, recognizing its potential to transform therapeutic strategies.

Global Targeted Protein Degradation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global targeted protein degradation market report based on type, application, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • PROTAC
  • Molecular Glues
  • LYTACs
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery
  • Therapy Development
    • Cancer
    • Neurology
    • Infectious Diseases
    • Cardiovascular Diseases
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Clinical Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Targeted Protein Degradation Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing frequency of chronic diseases
      • 3.2.1.2. Research and development activities
      • 3.2.1.3. Increasing recognition of the therapeutic potential of targeted protein degradation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations associated with approvals for novel TPD based therapies
  • 3.3. Targeted Protein Degradation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Targeted Protein Degradation Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Targeted Protein Degradation Market Type Movement Analysis
  • 4.3. Global Targeted Protein Degradation Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. PROTAC
    • 4.4.1. PROTAC market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Molecular Glues
    • 4.5.1. Molecular Glues market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. LYTACs
    • 4.6.1. LYTACs market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Targeted Protein Degradation Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Targeted Protein Degradation Market Application Movement Analysis
  • 5.3. Global Targeted Protein Degradation Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Drug Discovery
    • 5.4.1. Drug Discovery market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Therapy Development
    • 5.5.1. Therapy Development market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.2. Cancer
      • 5.5.2.1. Cancer market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.3. Neurology
      • 5.5.3.1. Neurology market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.4. Infectious Diseases
      • 5.5.4.1. Infectious Diseases market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.5. Cardiovascular Diseases
      • 5.5.5.1. Cardiovascular Diseases market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.5.6. Others
      • 5.5.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Targeted Protein Degradation Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Targeted Protein Degradation Market End Use Movement Analysis
  • 6.3. Global Targeted Protein Degradation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Academic & Research Institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Hospitals & Clinical Laboratories
    • 6.6.1. Hospitals & Clinical Laboratories market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Targeted Protein Degradation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory framework
      • 7.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Regulatory framework
      • 7.5.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Middle East and Africa
    • 7.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Bayer AG
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Bio-Techne
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. BOC Sciences
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. BPS Bioscience, Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. BroadPharm
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. LifeSensors Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. MedChemExpress.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Merck KGaA
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Promega Corporation
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Type benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Thermo Fisher Scientific, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Type benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global Targeted protein degradation market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 4 Global Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America Targeted protein degradation market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 8 North America Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 9 North America Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 11 U.S. Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 12 U.S. Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 14 Canada Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 17 Mexico Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe Targeted protein degradation market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 21 Europe Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 22 Europe Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 23 Germany Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 24 Germany Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 25 Germany Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 26 UK Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 27 UK Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 28 UK Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 30 France Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 31 France Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 33 Italy Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 34 Italy Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 36 Spain Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 37 Spain Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 39 Denmark Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 40 Denmark Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 42 Sweden Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 43 Sweden Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 45 Norway Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 46 Norway Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Targeted protein degradation market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 52 China Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 53 China Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Japan Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 55 Japan Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 56 Japan Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 57 India Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 58 India Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 59 India Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 61 South Korea Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Korea Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 64 Australia Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 65 Australia Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Thailand Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 67 Thailand Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 68 Thailand Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Latin America Targeted protein degradation market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 71 Latin America Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 72 Latin America Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Brazil Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 74 Brazil Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 75 Brazil Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Argentina Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 77 Argentina Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 78 Argentina Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 79 Middle East and Africa Targeted protein degradation market, by country, 2021 - 2033 (USD Million)
  • Table 80 Middle East and Africa Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 81 Middle East and Africa Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 82 Middle East and Africa Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 84 South Africa Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Africa Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 89 UAE Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 90 UAE Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Targeted protein degradation market, by type, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Targeted protein degradation market, by application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Targeted protein degradation market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Targeted protein degradation market: Market outlook
  • Fig. 5 Targeted protein degradation market: Segment outlook
  • Fig. 6 Targeted protein degradation market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Targeted protein degradation market driver impact
  • Fig. 9 Targeted protein degradation market restraint impact
  • Fig. 10 Targeted protein degradation market: Type outlook and key takeaways
  • Fig. 11 Targeted protein degradation market: Type movement analysis
  • Fig. 12 PROTAC market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 13 Molecular glues market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 14 LYTACs market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 15 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Targeted protein degradation market: Application outlook and key takeaways
  • Fig. 17 Targeted protein degradation market: Application movement analysis
  • Fig. 18 Drug discovery market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Therapy development market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Cancer market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Neurology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Infectious diseases market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Cardiovascular diseases market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Targeted protein degradation market: End Use outlook and key takeaways
  • Fig. 26 Targeted protein degradation market: End Use movement analysis
  • Fig. 27 Pharmaceutical & biotechnology companies market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 28 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Hospitals & clinical laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Global Targeted protein degradation market: Regional outlook and key takeaways
  • Fig. 32 Global Targeted protein degradation market: Regional movement analysis
  • Fig. 33 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Target Disease Prevalence
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Target Disease Prevalence
  • Fig. 40 Key country dynamics
  • Fig. 41 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Target Disease Prevalence
  • Fig. 43 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Target Disease Prevalence
  • Fig. 47 Key country dynamics
  • Fig. 48 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Target Disease Prevalence
  • Fig. 50 Key country dynamics
  • Fig. 51 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Target Disease Prevalence
  • Fig. 53 Key country dynamics
  • Fig. 54 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Target Disease Prevalence
  • Fig. 56 Key country dynamics
  • Fig. 57 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Target Disease Prevalence
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Target Disease Prevalence
  • Fig. 62 Key country dynamics
  • Fig. 63 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Target Disease Prevalence
  • Fig. 65 Key country dynamics
  • Fig. 66 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Target Disease Prevalence
  • Fig. 68 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Target Disease Prevalence
  • Fig. 72 Key country dynamics
  • Fig. 73 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Target Disease Prevalence
  • Fig. 75 Key country dynamics
  • Fig. 76 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Target Disease Prevalence
  • Fig. 78 Key country dynamics
  • Fig. 79 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Target Disease Prevalence
  • Fig. 81 Key country dynamics
  • Fig. 82 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Target Disease Prevalence
  • Fig. 84 Key country dynamics
  • Fig. 85 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Target Disease Prevalence
  • Fig. 87 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Target Disease Prevalence
  • Fig. 91 Key country dynamics
  • Fig. 92 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Target Disease Prevalence
  • Fig. 94 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Target Disease Prevalence
  • Fig. 98 Key country dynamics
  • Fig. 99 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Target Disease Prevalence
  • Fig. 101 Key country dynamics
  • Fig. 102 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Target Disease Prevalence
  • Fig. 104 Key country dynamics
  • Fig. 105 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 106 Target Disease Prevalence